Mechanisms of antimicrobial resistance in Acinetobacter baumannii

被引:0
作者
Vila, J [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Sch Med, Dept Microbiol,Lab Microbiol, E-08036 Barcelona, Spain
关键词
Acinetobacter; A-baumannii; antimicrobial agents; resistance;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This article reviews current knowledge of the mechanisms of resistance of Acinetobacter spp to antimicrobial agents. As will be seen although the evidence has not been completely demonstrated, it seems that a decrease in membrane permeability, in conjunction with a probable active efflux system, confers an important intrinsic resistance on this microorganism. This natural resistance may be increased by resistance acquired by the transfer of genetic elements (plasmids, transposons and integrons), as in the case of beta-lactamase acquisition (TEM-1, TEM-2, OXA-21) or the aminoglycoside-modifying enzymes (APH(3')VI, AAC(3)Ia). This transfer may take place by conjugation or natural transformation, and both processes occur not only in animate (e.g. the skin, the gastrointestinal tract) but also in inanimate reservoirs. Moreover, the selective pressure exercised by the antibiotic in these reservoirs may select resistant mutants (e.g. resistance to quinolones). Thus, Acinetobacter, and more specifically A. baumannii, has all the necessary conditions to acquire multiresistance and it may therefore be considered the paradigm of multiresistant bacteria. (C) 1998 Chapman & Hall.
引用
收藏
页码:87 / 97
页数:11
相关论文
共 74 条
[1]  
Acar J F, 1993, Drugs, V45 Suppl 3, P24
[2]  
[Anonymous], AM J MED
[3]   AMINOGLYCOSIDE-MODIFYING ENZYMES IN CLINICAL ISOLATES OF ACINETOBACTER-CALCOACETICUS [J].
BERGOGNEBEREZIN, E ;
JOLY, ML ;
MOREAU, N ;
LEGOFFIC, F .
CURRENT MICROBIOLOGY, 1980, 4 (06) :361-364
[4]   AN UNDERESTIMATED NOSOCOMIAL PATHOGEN, ACINETOBACTER-CALCOACETICUS [J].
BERGOGNEBEREZIN, E ;
JOLYGUILLOU, ML .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (05) :535-537
[5]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[6]  
BLANCHARD A, 1992, FEMS MICROBIOL LETT, V95, P277
[7]   DELINEATION OF NEW PROTEOLYTIC GENOMIC SPECIES IN THE GENUS ACINETOBACTER [J].
BOUVET, PJM ;
JEANJEAN, S .
RESEARCH IN MICROBIOLOGY, 1989, 140 (4-5) :291-299
[8]   IDENTIFICATION AND BIOTYPING OF CLINICAL ISOLATES OF ACINETOBACTER [J].
BOUVET, PJM ;
GRIMONT, PAD .
ANNALES DE L INSTITUT PASTEUR-MICROBIOLOGIE, 1987, 138 (05) :569-578
[9]   NOSOCOMIAL OUTBREAKS DUE TO AMIKACIN-RESISTANT TOBRAMYCIN-SENSITIVE ACINETOBACTER SPECIES - CORRELATION WITH AMIKACIN USAGE [J].
BUISSON, Y ;
VANNHIEU, GT ;
GINOT, L ;
BOUVET, P ;
SCHILL, H ;
DRIOT, L ;
MEYRAN, M .
JOURNAL OF HOSPITAL INFECTION, 1990, 15 (01) :83-93
[10]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233